triumph 1 trial retatrutide First phase 3 data, a of Science! 57 days in Triumph-1 trial, – Triumph-1 Trial: 28.3% Weight Loss

Decreased risk of anxiety in diabetic patients receiving glucagon-like peptide-1 receptor agonist: a nationwide, population-based cohort study

Conservatively, the first Phase 1 data could appear at a late 2026 conference or in early 2027

B12s role in creating red blood cells also means better oxygen circulation throughout your body, which is vital for nourishing your skin and scalp

Try not to skip meals

Very interesting paper on an important topic SGLT2is, GLP-1RAs and nsMRAs has significantly transformed clinical guidelines in recent decades shiowing numerous positive including CV and nephroprotection In type 2 diabetes, early evidence suggests that integrating these treatments may offer superior survival and cardiovascular outcomes compared to using single agents